MedPath

MSG and Gastrointestinal Motility

Not Applicable
Completed
Conditions
Gastroesophageal Reflux
Interventions
Dietary Supplement: Sodium chloride
Dietary Supplement: Monosodium glutamate
Registration Number
NCT01009658
Lead Sponsor
Gunma University
Brief Summary

The purpose of this study is to clarify the physiological function of sodium glutamate by measuring its effect on upper GI motility ( gastric emptying).

Detailed Description

Amino acids such as monosodium glutamate are known to stimulate both endocrine and exocrine secretion. In addition, there is a report that oral intake of glutamate evokes the activation of vagal afferent nerves in the rat. Thus, such amino acids are thought to be influential in the process of digestion and absorption.

. To investigate the effect of monosodium glutamate on gastrointestinal motility, we planned a single-blind randomized study. The participants will take either monosodium glutamate or sodium chloride before the first examination of upper GI motility and the other agent before the second examination. The order of intake will be randomized by the envelope method.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Healthy subjects
  • Must not have digestive symptoms
  • Must not eat within six hours of study participation
Exclusion Criteria
  • Regular medications for the gastrointestinal tract
  • Previous Helicobacter pylori infection
  • Previous abdominal surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
NaCl firstSodium chloride-
MSG firstMonosodium glutamate-
Primary Outcome Measures
NameTimeMethod
Gastric emptying0-5 hours

half emptying time

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gunma university hospital

🇯🇵

Maebashi, Gunma, Japan

© Copyright 2025. All Rights Reserved by MedPath